United States Aesthetic Devices Market Outlook to 2025 - Aesthetic Fillers and Aesthetic Implants

1.1 List of Tables
1.2 List of Figures

2.1 What Is This Report About?
2.2 Aesthetic Devices Market Segmentation
2.3 Definitions of Markets Covered in the Report

3.1 Aesthetic Devices Market, United States, Revenue ($m), 2015-2025
3.1.1 Aesthetic Fillers Market, United States, Revenue ($m), by Segment, 2015-2025
3.1.2 Aesthetic Implants Market, United States, Revenue ($m), by Segment, 2015-2025
3.2 Aesthetic Devices Market, United States, Volume (Units), 2015-2025
3.2.1 Aesthetic Fillers Market, United States, Volume (Units), by Segment, 2015-2025
3.2.2 Aesthetic Implants Market, United States, Volume (Units), by Segment, 2015-2025
3.3 Aesthetic Devices Market, United States, Average Price ($), 2015-2025
3.4 Aesthetic Devices Market, United States, Distribution Share by Revenue ($m), 2019
3.5 Aesthetic Devices Market, United States, Company Share by Revenue ($m), 2019

4.1 Allergan Ltd
4.1.1 Company Overview
4.2 Mentor Worldwide LLC
4.2.1 Company Overview
4.3 Merz Pharma GmbH & Co KgaA
4.3.1 Company Overview
4.4 Galderma SA
4.4.1 Company Overview
4.5 Boston Scientific Corp
4.5.1 Company Overview
4.6 Sientra Inc
4.6.1 Company Overview
4.7 Coloplast A/S
4.7.1 Company Overview

6.1 Equity Offerings
6.1.1 Cutera Raises USD28.8 Million in Public Offering of Shares
6.1.2 SANUWAVE Health Raises USD2.25 Million in Private Placement of Series C Convertible Preferred Stock
6.1.3 Establishment Labs Raises USD69 Million in Public Offering of Shares
6.1.4 Misonix Prices Public Offering of Shares for USD30 Million
6.1.5 NanoVibronix Files Registration Statement for Public Offering of Securities for up to USD11.9 Million
6.1.6 InMode Aesthetic Solutions May Raise Funds through Public Offering of Shares
6.1.7 Avita Medical Raises USD15.4 Million in Private Placement of Shares
6.1.8 InMode Aesthetic Solutions Underwriters Exercise of Over-Allotment Option of IPO of Shares for USD77 Million
6.1.9 NanoVibronix Raises USD3.2 Million in Private Placement of Convertible Preferred Stock
6.2 Partnerships
6.2.1 Suneva Medical Enters into Partnership with Sinclair Pharma
6.3 Private Equity
6.3.1 Clayton, Dubilier & Rice Acquires Cynosure from Hologic for USD205 Million
6.4 Venture Financing
6.4.1 Suneva Medical Raises USD25.1 Million in Venture Financing
6.4.2 Suneva Medical Raises USD5 Million in Venture Financing
6.4.3 Surgical Innovation Associates Raises USD4 Million in Series A Financing
6.4.4 Suneva Medical Raises USD2.5 Million in Venture Financing

7.1 Corporate Communications
7.1.1 Mar 12, 2020: Plus Therapeutics welcomes two new Directors
7.1.2 Feb 06, 2020: Plus Therapeutics appoints Chief Financial Officer
7.1.3 Feb 06, 2020: Plus Therapeutics announces changes to its Board of Directors
7.1.4 Jan 07, 2020: Dyve Biosciences announces Chuck Harbert, Ph.D. to join as Chief Scientific Officer
7.1.5 Jan 02, 2020: Plus Therapeutics appoints Dr. An van Es-Johansson to board of directors
7.1.6 Dec 10, 2019: Sciton’s recent User Summit Held in Dallas broke new records
7.1.7 Dec 09, 2019: Diane Gomez-Thinnes appointed as worldwide president of mentor
7.1.8 Nov 18, 2019: Cutera appoints Fuad Ahmad as Interim CFO
7.1.9 Nov 13, 2019: Bausch + Lomb And TerraCycle announce donation of new custom training modules incorporating used contact lens Materials to Guide Dog Foundation
7.1.10 Nov 12, 2019: Merz forms fully focused global medical aesthetics business: Merz Aesthetics
7.1.11 Oct 24, 2019: Aspen Laser receives award from Global Health & Pharma
7.1.12 Aug 16, 2019: Merz announces key governance changes
7.1.13 Aug 12, 2019: Cutera announces planned retirement of David B. Apfelberg, M.D., as member of the board of directors
7.1.14 Jul 24, 2019: AirXpanders announces board changes
7.1.15 Jul 09, 2019: Cutera announces appointment of David Mowry as Chief Executive Officer
7.2 Financial Announcements
7.2.1 Feb 26, 2020: Cutera, Inc. Announces Fourth Quarter and Full-Year 2019 Financial Results
7.2.2 Feb 12, 2020: CHF solutions expands commercial presence in Europe with distribution arrangement for Germany, Austria and Switzerland
7.2.3 Jan 28, 2020: Establishment Labs announces preliminary results for fourth quarter and full year 2019; reports record revenue
7.2.4 Jan 13, 2020: Misonix reports preliminary fiscal 2020 second quarter revenue of approximately $19.7 million
7.2.5 Jan 12, 2020: Cutera announces preliminary financial results for fourth quarter and full-year 2019
7.2.6 Nov 15, 2019: SANUWAVE health reports third quarter 2019 financial results
7.2.7 Nov 07, 2019: Cutera reports third quarter 2019 financial results
7.2.8 Sep 23, 2019: MOCA I acute heart attack data to be presented at TCT19
7.2.9 Aug 15, 2019: SANUWAVE Health reports second quarter 2019 financial results
7.2.10 Aug 14, 2019: Misonix reports fourth quarter and fiscal year 2019 results
7.2.11 Aug 08, 2019: Cutera reports second quarter 2019 financial results
7.3 Legal And Regulatory
7.3.1 Mar 10, 2020: Cutera claims Lutronic stole trade secrets
7.3.2 Dec 16, 2019: Bausch Health Resolves Stock Drop Litigation initially filed in October 2015
7.3.3 Oct 30, 2019: SANUWAVE successfully completes extensive round of quality system and technical file audits
7.3.4 Jul 16, 2019: Candela and Lumenis announce settlement of patent infringement lawsuit
7.3.5 Jun 20, 2019: SEC investigation of Misonix ends with no action
7.4 Other Significant Developments
7.4.1 Feb 24, 2020: AbbVie announces extension of expiration date for exchange offers for Allergan notes
7.4.2 Dec 16, 2019: Eclipse obtains major quality and regulatory milestone
7.5 Product News
7.5.1 Dec 04, 2019: Cartessa Aesthetics releases Subnovii Plasma Technology to the US Marketplace
7.5.2 Dec 02, 2019: NanoVibronix to present at two investor conferences in December
7.5.3 Oct 17, 2019: Dyve Biosciences to present at the 2019 BIO Investor Forum
7.5.4 Oct 03, 2019: Dyve Biosciences to highlight the power and potential of transdermal drug delivery at PODD 2019
7.6 Strategy And Business Planning
7.6.1 Feb 03, 2020: Candela to market MT.DERM's medical microneedling products
7.6.2 Nov 21, 2019: Hologic to divest Cynosure medical aesthetics unit for $205m
7.6.3 Nov 12, 2019: BD submits Pre-Market approval supplement to FDA for BD Onclarity HPV Test with extended genotyping capabilities

8.1 Research Methodology
8.1.1 Coverage
8.1.2 Secondary Research
8.1.3 Primary Research
8.1.4 Market Modeling and Forecasting
8.1.5 Company Share Analysis
8.1.6 Distribution Share Analysis
8.1.7 Benchmarking
8.2 The Publisher's Consulting
8.3 Contact
8.4 Disclaimer

Table 1: Aesthetic Devices Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 2: Aesthetic Devices Market, United States, Revenue ($m), USD Constant, 2021-2025
Table 3: Aesthetic Fillers Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 4: Aesthetic Fillers Market, United States, Revenue ($m), USD Constant, 2021-2025
Table 5: Aesthetic Implants Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 6: Aesthetic Implants Market, United States, Revenue ($m), USD Constant, 2021-2025
Table 7: Aesthetic Devices Market, United States, Volume (Units), 2015-2020
Table 8: Aesthetic Devices Market, United States, Volume (Units), 2021-2025
Table 9: Aesthetic Fillers Market, United States, Volume (Units), 2015-2020
Table 10: Aesthetic Fillers Market, United States, Volume (Units), 2021-2025
Table 11: Aesthetic Implants Market, United States, Volume (Units), 2015-2020
Table 12: Aesthetic Implants Market, United States, Volume (Units), 2021-2025
Table 13: Aesthetic Devices Market, United States, Average Price ($), 2015-2020
Table 14: Aesthetic Devices Market, United States, Average Price ($), 2021-2025
Table 15: Aesthetic Devices Market, United States, Distribution Share by Revenue ($m), USD Constant, 2019
Table 16: Aesthetic Devices Market, United States, Company Share by Revenue ($m), USD Constant, 2019
Table 17: Aesthetic Devices Market Pipeline Products
Table 18: Cutera Raises USD28.8 Million in Public Offering of Shares
Table 19: SANUWAVE Health Raises USD2.25 Million in Private Placement of Series C Convertible Preferred Stock
Table 20: Establishment Labs Raises USD69 Million in Public Offering of Shares
Table 21: Misonix Prices Public Offering of Shares for USD30 Million
Table 22: NanoVibronix Files Registration Statement for Public Offering of Securities for up to USD11.9 Million
Table 23: InMode Aesthetic Solutions May Raise Funds through Public Offering of Shares
Table 24: Avita Medical Raises USD15.4 Million in Private Placement of Shares
Table 25: InMode Aesthetic Solutions Underwriters Exercise of Over-Allotment Option of IPO of Shares for USD77 Million
Table 26: NanoVibronix Raises USD3.2 Million in Private Placement of Convertible Preferred Stock
Table 27: Suneva Medical Enters into Partnership with Sinclair Pharma
Table 28: Clayton, Dubilier & Rice Acquires Cynosure from Hologic for USD205 Million
Table 29: Suneva Medical Raises USD25.1 Million in Venture Financing
Table 30: Suneva Medical Raises USD5 Million in Venture Financing
Table 31: Surgical Innovation Associates Raises USD4 Million in Series A Financing
Table 32: Suneva Medical Raises USD2.5 Million in Venture Financing
Table 33: Total Number of Primary Research Participants, General Surgery Market, by Country

Figure 1: Aesthetic Devices Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 2: Aesthetic Fillers Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 3: Aesthetic Implants Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 4: Aesthetic Devices Market, United States, Volume (Units), 2015-2025
Figure 5: Aesthetic Fillers Market, United States, Volume (Units), 2015-2025
Figure 6: Aesthetic Implants Market, United States, Volume (Units), 2015-2025
Figure 7: Aesthetic Devices Market, United States, Company Share (%) 2019